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Abstract 
Although a number of studies support a reciprocal inverse association between diagnoses of cancer and 
Alzheimer’s disease (AD), to date there has not been any systemic investigation of the neurobiological 
impact of or genetic risk factors underlying this effect.  To facilitate this goal, this study aimed to 
replicate the inverse association of cancer and AD using data from the NIA Alzheimer’s Disease 
Neuroimaging Initiative, which includes age-matched cases and controls with information on cancer 
history, AD progression, neuroimaging, and genomic data.  Subjects included individuals with AD 
(n=234), mild cognitive impairment (MCI, n=542), and healthy controls (HC, n=293).  After controlling for 
sex, education, race/ethnicity, smoking, and apolipoprotein E (APOE) e2/3/4 allele groups, cancer 
history was protective against baseline AD diagnosis (p=0.042), and was associated with later age of AD 
onset (p=0.001).  Cancer history appears to result in a cumulative protective effect; individuals with 
more than one cancer had a later age of AD onset compared to those with only one cancer (p=0.001).  
Finally, a protective effect of AD was also observed in individuals who developed incident cancer after 
enrolling (post-baseline visit); 20 individuals with MCI and 9 HC developed cancer, while no AD patients 
had subsequent cancer diagnoses (p=0.013).  This supports previous research on the inverse association 
of cancer and AD, and importantly provides novel evidence that this effect appears to be independent of 
APOE, the major known genetic risk factor for AD. Future analyses will investigate the neurobiological 
and genetic basis of this effect.  
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